Assessment of clinical trials registered at clinical trial registry of India over past decade: an audit
Background: Clinical trial registry of India (CTRI) was launched in 2007. In this audit we attempted to assess the clinical research scenario over the past decade by looking at the information about clinical studies registered at the CTRI from 2007 to 2016.
Methods: We accessed the official website of the CTRI i.e. www.ctri.nic.in and the required information was downloaded and descriptive statistics were used.
Results: We found that the number of studies went on increasing from 31 in 2007 to 7060 in 2016 (as on 22nd June 2016). Majority studies were of interventional in nature as compared to observational and bioavailability and bioequivalence (BABE) studies. Pharmaceutical industry sponsored studies were comparatively higher in number than any other sponsored studies. However their number went on decreasing, while increase in registration of post graduate thesis and investigator sponsored studies was observed.
Conclusions: Though a decrease in Pharmaceutical industry sponsored studies was observed the overall clinical research scenario appears to have improved due to investigator initiated studies and post graduate thesis.
Available at http://ctri.nic.in/Clinicaltrials/cont1.php Accessed 3 September 2016.
Available at http://www.cdsco.nic.in Accessed 3 September 2016.
General Statutory Rules (GSR) 944 (E) 1988. Available at http://dbtbiosafety.nic.in/Files/CD_IBSC/Files/Cosmetic.pdf Accessed 3 September 2016.
Schedule Y. New Delhi: 2005. Jan 20, Amended Schedule Y [Drug and Cosmetic act (2nd amendment) rules] Available at http://www.cdsco.nic.in/html/scheduleY%20 (Amended%20Version2005)%20original.htm Accessed 3 September 2016.
Mondal S, Abrol D. Clinical trials industry in India: A Systematic Review. Working paper 179 March 2015. Available at http://isid.org.in/pdf/WP179.pdf Accessed 3 September 2016.
Central Drug Standard Control Organization. Targeted Timelines for Approvals of Complete Applications by DCG (I) office. Available at http://www.cdsco.nic.in/revised_new_timelines.pdf Accessed 3 September 2016.
Chaudhuri S. Is Product Patent Protection Necessary in Developing Countries for Innovation? R&D by Indian Pharmaceutical Companies after TRIPS. WPS No. 614/ September 2007. Available at https://www.iprsonline.org/resources/docs/Sudip-WP-India-R&D-TRIPS-Sept-2007.pdf Accessed 3 September 2016.
SAE reporting and Compensation. GSR 53E, January 30, 2013. Available at http://www.cdsco.nic.in/writereaddata/GSR%2053 (E).pdf Accessed 3 September 2016.
Conditions to be fulfilled by the sponsor to conduct the clinical trial. GSR 63E February 1, 2013 Available at http://cdsco.nic.in/writereaddata/GSR%2063(E)%20dated01%20.02.2013.pdf Accessed 3 September 2016.
Registration of Ethics Committees. GSR72 E, February 8, 2013. Available at http://cdsco.nic.in/writereaddata/G.S.R%2072(E)%20dated%2008.02.2013.pdf Accessed 3September 2016.
Office Order, Audio-visual recording of informed consent of process, November 19, 2013. Available at http://www.cdsco.nic.in/writereaddata/Office%20Order%20dated%20 19.11.2013.pdf Accessed 3September 2016.
Compensation Formula (Clinical Trial). 2013. Available at http://www.cdsco.nic.in/writereaddata/formula2013SAE.pdf Accessed 3 September 2016.
Bhide SS, Jalgaonkar SV, Katkar JV, Shetty YC,
Tripathi RK, Marathe PA, et al. Impact of recent
regulatory notifications on the institutional ethics committee of a tertiary-care teaching hospital in Mumbai. Indian J Med Ethics. Published online on July 19, 2016. Available at http://www.ijme.in/index.php/ijme/article/view/2432/5017 Accessed 3 September 2016.
Bajpai V. Rise of Clinical Trials Industry in India: An Analysis. Available at http://dx.doi.org/10.1155/2013/167059 Accessed 3 September 2016.